Introduction. Infertility treatments such as in vitro fertilization (IVF) impose substantial distress. However, the specific role of individual contributory factors remains unclear. We therefore compared treatment-related psychological stress in IVF treatments with (cIVF) and without (NC-IVF) gonadotropin stimulation, as cIVF includes potentially stressful factors such as ovarian stimulation, anesthesia, embryo selection and cryopreservation, whereas NC-IVF does not. Material and methods. Women were offered to have cIVF or NC-IVF. Validated psychological questionnaires filled in online before, during and after completed treatment cycle(s) at home were used to analyze psychological distress and treatment-related satisfaction and quality of life. To avoid different pregnancy rates in the two treatment groups, one cIVF was compared with three NC-IVF therapies, resulting in the same cumulative pregnancy rate. Results. Data from 57 NC-IVF and 62 cIVF patients were evaluated. NC-IVF resulted in a similar overall clinical pregnancy rate than one cIVF. NC-IVF patients had a significantly lower level of depression (CES-D, 13.4 vs. 15.7, p < 0.05) and a higher satisfaction with the treatment (Treatment FertiQoL, 67.9 vs. 62.9, p < 0.05) compared with cIVF patients. The level of psychological distress increased during c-IVF treatment and decreased during NC-IVF treatment. In contrast, during NC-IVF treatment there was a significant increase in satisfaction with the treatment, whereas satisfaction with treatment in the cIVF patients decreased. Conclusions. Factors other than just pregnancy rate seem to have an impact on psychological stress in IVF treatment. Due to reduced psychological stress in NC-IVF, this treatment could be especially considered in psychologically stressed women.
Introduction
Infertility (1) and infertility treatments such as in vitro fertilization (IVF) impose substantial distress (2, 3) .
Anxiety and depression are significantly increased in women with treatment failure several weeks after the first IVF treatment (4) and also six months after treatment (4) . Many couples stop treatment prematurely because of the psychological stress, thus reducing the chances of success (5) . However, it is unclear whether the psychological stress also influences the chance of conception. However, a prospective study (6) revealed that anxiety and depression have no influence on the pregnancy rates of a first IVF treatment.
But what exactly imposes stress on women undergoing an IVF therapy? It can be assumed that a broad spectrum of factors will have an impact. Even though success or failure of the treatment will certainly have the highest impact, several other factors such as fear of the hormonal stimulation, daily injections and the risk of multiple pregnancies will be relevant. Even factors such as embryo selection and cryopreservation of embryos (7) can impose anxiety and stress on the couples. The diversity of potentially negative factors and individual psychological differences make it impossible for a dedicated evaluation of the importance of the individual influencing factors.
It was therefore obvious to examine the sum of all these potential factors, and compare the psychological burden of conventional IVF therapy with high-dose gonadotropin stimulation (cIVF) where all the named factors apply, with that of natural cycle IVF (NC-IVF) therapy without gonadotropin stimulation, in which the above factors play only a minor role.
A prospective longitudinal study was therefore carried out, in which the psychological burden of cIVF and three consecutive NC-IVF treatments in an unselected sample of fertility treatment patients was measured before and during as well as after IVF treatment. The two arms of the study were chosen in this form, as cIVF with transfer and three NC-IVF treatments lead to a similar cumulative pregnancy chance and a similar number of consultations (8) .
Material and methods

Study design
The present study is a prospective, non-randomized study with consecutive, infertile patients who underwent cIVF or NC-IVF at the University Woman's Hospital of Berne Fertility Center (Switzerland). Recruitment took place between May 2013 and December 2014.
Participants
Women between 18 and 42 years of age who had indications for IVF therapy were offered NC-IVF therapy or cIVF treatment and were invited to participate in the study. Whether cIVF or NC-IVF was carried out depended on the medical indication and the patient's wishes. The exclusion criterion for NC-IVF was an irregular menstrual cycle and for cIVF was anti-mullerian hormone <0.5 ng/mL. Further exclusion criteria for the study participation were current psychological treatment, serious psychiatric illness and insufficient knowledge of German. The women were counseled in accordance with our study results described elsewhere (8) . These studies revealed that treatment time to achieve a pregnancy is 30% longer in NC-IVF, whereas costs per achieved pregnancy are 30% lower. Based on these exclusion criteria and information, women opted for cIVF or NC-IVF. As it was impossible to calculate the number of participants required in our study, the number of participants was based on other previously published studies, using the Fertility Quality of Life Questionnaire (FertiQoL). , MSD Merck Sharp & Dohme GmbH) was administered subcutaneously to trigger final oocyte maturation. Transvaginal oocyte retrieval was scheduled 36 h after hCG administration and performed under general anesthesia, using an 18-gauge monoluminal aspiration needle (Cook, Queensland, Australia). One to two embryos were transferred two to three days after aspiration.
NC-IVF patients received no stimulation at all or very low dosages of clomifene citrate (25 mg orally per day) from day 6 or 7 of the menstrual cycle until the day of ovulation induction to reduce the risk of premature
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Natural cycle IVF induces less psychological stress than conventional IVF with gonadotropin stimulation, indicating that other factors such as ovarian stimulation, anesthesia, embryo selection and cryopreservation might also contribute to the induction of psychological stress. ovulation as described elsewhere (8) . One consultation took place around days 10-12 [15 min, transvaginal ultrasound and serum analysis of luteinizing hormone (LH) and E2)]. When the follicle diameter was expected to reach at least 16 mm and E2-concentration was expected to be ≥700 pmol/L, 5000 IU hCG was administered subcutaneously 36 h before oocyte retrieval, which was performed without anesthesia using a 19-gauge needle (Kitazato, Tokyo, Japan). One embryo was transferred two to three days after aspiration. At 14 days after the embryo transfer, a blood test was performed to analyze hCG concentration. The analysis was finalized as soon women became pregnant, but not later than after three NC-IVF treatment cycles.
Psychological evaluation
The patients were asked to complete the validated psychological questionnaires shown below before and after one cIVF cycle or before and after three NC-IVF treatments. For NC-IVF therapy, an additional assessment was performed on the day of the first consultation, around day 10-12 of each treatment cycle [Infertility Distress Scale (IDS); Center for Epidemiologic Studies Depression Scale (CES-D) and FertiQoL], corresponding to five measurement points: t1 (Pre), t2, t3, t4 and t5 (Post). All outcome measures were collected in the NC-IVF group, except the Brief Symptom Inventory (BSI) and World Health Organization Quality of Life (WHOQOL) questionnaire, which were only measured at t1 and t5.
The questionnaires were uploaded to an online platform to allow patients to complete them at home and to exclude the influence of the physician on the survey. Patients were asked to complete the questionnaires at the respective time intervals via an email sent by the principal investigator.
Outcome measures
The following basic demographic information was collected at baseline: age, prior psychological treatment, how long the woman had been trying to conceive, type of and reason for sterility and previous infertility-related medical treatment. Following the IVF therapy, a second assessment of medical treatment, supplementary psychological support, and pregnancy status was performed.
Infertility Distress Scale (9)
The IDS is an 11-item validated scale that assesses infertile patients' level of mental distress stemming from infertility. Representative items include: "How upset were you the last time you learned, despite your hopes, that you had not become pregnant?"; "How upsetting is your unfulfilled wish for a child at present?"; "How much distress do you currently experience at work?" and "How much distress do you currently experience in your relationship (aside from problems related to your unfulfilled wish for a child)?" IDS scores ranged from 0 (none at all) to 4 (very intense). A cut-off score of 21 indicates a clinically relevant level of distress. In our sample, Cronbach's alpha was 0.82 at baseline.
Fertility Quality of Life (FertiQoL, 10)
The FertiQoL assesses the impact of fertility problems in various areas of life (for example, family, partnership, working life, self-esteem, emotions and overall health). FertiQoL comprises 36 items with a rating scale of 0 (very poor, very dissatisfied, totally, always, extremely strong) to 4 (very good, very satisfied, not at all, never). Higher values mean that the quality of life is judged as being higher. The test consists of six subscales and three total scales, with a range of 0-100. The total scale Core FertiQoL describes the average quality of life relating to fertility in all core domains. The scale Treatment FertiQoL rates the quality of life in terms of treatment domains. This includes the subscales treatment environment (environment or availability and quality of treatment) and treatment tolerability (tolerability or mental and physical symptoms due to treatment). With the scale FertiQoL Total scale, an average internal consistency of a = 0.89 was achieved over the five measurement points.
Center for Epidemiologic Studies Depression Scale (CES-D, 11)
The CES-D quantifies the severity of depressive symptomatology and consists of 20 items, which are measured using a scale from 0 (barely) to 3 (mostly, constantly). Scores range from 0 to 60, with scores of 16 or higher reflecting clinical relevant depressive symptoms. A value of 22 or more signals a major depression (11, 12) . At baseline, Cronbach's alpha for the CES-D was 0.89.
Brief Symptom Inventory (BSI, 13)
The BSI is the short version of the Symptom Checklist (SCL-90-R). The BSI measures a person's perceived disturbance by physical and psychological symptoms over a period of seven days. It comprises 53 items grouped into nine scales. These scales describe the areas: somatization, compulsiveness, insecurity in social contact, depression, anxiety, aggressiveness/hostility, phobic anxiety, paranoid thinking and psychoticism. The global value Global Severity Index (GSI) represents the most sensitive indicator of the psychological burden, because it measures the intensity of perceived stress in all 53 items. The response format ranges from 0 (not at all) to 4 (very strong). Higher values mean that the burden is judged to be higher. The standard Global Value BSI GSI value in women is mean (M) = 0.35. For the depression scale M = 0.33, for the anxiety scale M = 0.39 and the aggression scale M = 0.37. An internal consistency of a = 0.95 was achieved over the five measurement points for the BSI GSI scale, which corresponds with a very high internal consistency.
WHO Quality of Life Bref (WHOQOL-Bref, 14)
The short version of the WHO Quality of Life (WHO-QOL-Bref) is an instrument for the assessment of subjective quality of life. The basis of the instrument is the definition of quality of life as the individual perception of one's own life in the context of the respective culture and system of values and in terms of personal goals, expectations, standards of judgment and interests. The short version of WHOQOL consists of 26 items and measures the dimensions: global quality of life, physical well-being, mental well-being, social relationships and environment. The items are rated on a five-level Likert scale from 1 (very poor, very dissatisfied, not at all, never) to 5 (very good, very satisfied, extremely, completely, always).
The higher the values of the items in the WHOQOLBref, the higher the subjective quality of life is rated to be. The standard value of the WHOQOL Global scale is a total of M = 67.8 (SD = 16.7). For women aged 26-35, M = 72.49, and for women aged 36-45 years, M = 68.72 (14) . The mean internal consistency of the scale WHO-QOL Global over the measurement points (t1, t5) is a = 0.63.
Statistical analyses
Patients' baseline characteristics were compared using the t-test (age, duration of infertility and anti-mullerian hormone concentration) or by Chi-square test. Differences in the psychological distress post-assessment were proven by U-tests. Assumptions for an ANOVA are not met. Therefore changes over the treatment phase of the NC-IVF therapy in outcome measures were analyzed using the non-parametric Friedman test. The Pearson correlation coefficient r served as the effect size for interval scale data. According to Cohen (15) , an effect under r = 0.1 to r = 0.3 represents a small effect, above r = 0.3 a medium effect, and above r = 0.5 a large effect.
Regarding the high number of missing values, we calculated all results by replacing the missing values with series means. Significance for the analyses was set at p < 0.05. Analyses were performed using the SPSS (Statistical Package For The Social Sciences) version 22.0 for Windows (SPSS, Inc., Chicago, IL, USA).
Ethical approval
The study was approved by the local ethical board committee (Internal Review Board, Inselspital Berne, 13-042) and patient approval was given by written consent. Informed consent was obtained in writing from all participants. Table 1 shows a summary of the demographic characteristics at baseline. Fifty-seven women underwent NC-IVF and 62 women cIVF therapy. Women ranged in age from 27 to 41 years, with an average age of 34.4. The mean duration of participants' wish for a child was 3.2 years (range 0.5-10 years) and 13 of the total 119 patients had made no use of any medical treatment before the actual medical therapy. Patient characteristics were not significantly different in both groups apart from duration of infertility. One woman undergoing cIVF was pregnant with twins. Table 2 Table 3 
Results
Patient characteristics
Psychological distress before IVF treatment
Psychological distress after IVF treatment
Psychological distress in NC-IVF before, after and during treatment
All outcome measures were collected in the NC-IVF group over five measurement points, except the BSI and WHOQOL questionnaires, which were only measured at t1 and t5. Table 4 shows there was a significant overall effect in Total FertiQoL over the five measurement points (Friedman test: F 4,57 = 26.824; p ≤ 0.01). In addition, the CES-D measured a significant overall effect for depressive symptoms (Friedman test: F 4,57 = 11.834, p = 0.019). 
Psychological distress in cIVF before and after treatment
Discussion
Our study revealed that, following three NC-IVF treatment cycles, women showed significantly fewer depressive symptoms and quality of life was better compared with that in women undergoing one cIVF treatment. However, it is on the whole unclear which factors are particularly psychologically stressful for the couples. Is it the fear of being unsuccessful (4,16) as a result of which, as many oocytes as possible are collected and the embryos undergo various selection processes in the laboratory? Or is it the fear of side effects of gonadotropin stimulation, such as possible ovarian hyperstimulation syndrome, mood changes and an increase in bodyweight, the fear of injections and anesthesia, fear of the manipulation of their oocytes and embryos by biologists or the fear of multiple pregnancies?
The influence of these factors on the mental state of the couple and thus their psychological stress has largely been unstudied in detail up to now. Advances in IVF treatments without gonadotropin stimulation, NC-IVF now represents an alternative form of treatment where pregnancy takes longer to occur but the success rate is good overall (8, 17) . Furthermore, the costs per pregnancy are lower (18) , with injections, anesthesia for oocyte collection and embryo selection not being required (19) . There are almost no multiple pregnancies, no ovarian hyperstimulation syndrome or other potential side effects of gonadotropin stimulation (8, 17) . NC-IVF was therefore chosen as a model in this study to evaluate the impact of all these potentially psychologically relevant influencing factors on the psyche of women by comparing it with cIVF. Table 4 . Test scores before (t1 = Pre), during treatment cycles 1-3 (t2-4) and after (t5 = Post) natural cycle IVF (NC-IVF) treatment; mean (SD).
Scales
Pre (n = 57) t2 (n = 34) t3 (n = 10) t4 (n = 23) Post (n = 44) However, a comparison of the therapies requires that the treatment groups are otherwise identical. This is one of the weaknesses of our study because, in practice, randomization of treatments is not feasible. It can therefore not be definitively ruled out that bias was present in the allocation of subjects to cIVF or NC-IVF. However, as both groups were not significantly different, apart from duration of infertility, regarding nonpsychological characteristics (Table 1) and were only partially different regarding psychological test scores (Table 2) , the risk of a significant bias is probably rather low. Furthermore, IVF treatments are not reimbursed in Switzerland. Therefore a bias based on the reimbursement system can be mostly excluded.
Other weaknesses are the limited sample size of the study, as well as the missing values at individual measurement points during NC IVF treatment.
Two studies have already examined the psychological burden of various IVF treatment protocols. However, both studies involved only cIVF treatments with high dosage of gonadotropins. Therefore these studies could not specifically reveal the impact of the gonadotropin stimulation itself and of the other above-mentioned treatment factors on the psychological condition of the patients.
Our study does not allow a definitive statement to be made about which treatment factors led to the increased psychological distress in cIVmF. However, the different results of the psychometric tests which assessed the overall psychological state (CES-D, BSI GSI, WHO Global) and the tests which assessed the influence of fertility treatment on quality of life (Treatment FertiQoL) allow conclusions to be made about why NC-IVF resulted in less distress. It seems that not only sterility, as investigated in previous studies (1, 4, 16) , but also the IVF treatment itself has a relevant impact on the psychological burden of patients.
Possible reasons for the lower psychological distress of NC-IVF treatment are the absence of gonadotropin stimulation, the natural and not artificially manipulated follicle recruitment, the absence of anesthesia during oocyte collection, the absence of embryo selection in the laboratory as well as the lower cost per treatment cycle. The influence of embryo selection and cryopreservation is the only one of these factors which has been examined. Svanberg et al. (7) reported that these procedures induced anxiety and stress in the couples.
Several studies have already investigated which factors lead to couples discontinuing IVF treatment, which could provide conclusions on psychologically relevant factors. Gameiro et al. (2012) conducted a systematic review and identified the following reasons for discontinuation of therapy with decreasing frequency: postponement of treatment, physical and psychological burden, relational and personal problems, treatment rejection, and organizational and clinic problems. Psychological burden was noted to be a reason for treatment discontinuation in 14%, physical burden in 6.3%, and treatment rejection in 13.2% of cases. Nevertheless, these studies summarized by Gameiro et al. (5) do not allow a detailed statement to be made about the importance of the various above-mentioned factors that influence the psychological state in conventional vs. NC-IVF therapy.
Whether the woman or the man is the driving force behind a discontinuation of treatment is also unanswered. We limited this study to women. Ying et al. (22) performed a systematic review to identify gender differences in emotional reactions in IVF treatments. As expected, men suffered less from the IVF treatment procedures and their anxiety levels were less affected. It can therefore be assumed that women have a higher impact on the psychological distress of the couple and contribute more to the decision to discontinue the IVF treatment.
In conclusion, NC-IVF therapies cause less psychological distress compared with conventional cIVF in relation to treatment-related factors. Accordingly, other factors than just pregnancy rate seem to have an impact on psychological stress in IVF treatment. Due to reduced psychological stress in NC-IVF this treatment could be especially considered in psychologically stressed women.
